Featured In The Buyers Guide
Grane Rx demonstrates how automating as many tasks as possible will be the baseline standard for success as the role of the pharmacist continues to evolve and expand. Read a case study of this critical foundation upon which all of pharmacy can step into the future.
Galva Pharmacy was the first in the United States to use artificial intelligence in SmartSuite from DrFirst to accurately translate e-prescriptions, helping avoid medication errors and saving time for each drug dispensed.
Making the switch to a new pharmacy system is a big step for a pharmacy, and to do this during the COVID-19 pandemic had additional considerations. One health center aspired to improve its reporting and discovered that a new workflow module offered functionality and more services to customers. Learn how Health Care Partners of South Carolina switched to Computer-Rx for its enhanced reporting features, and was surprised with the added benefits that came along with the workflow features.
Ken Patel, R.Ph., added RxSafe RapidPakRx adherence packaging automation to Rightway Pharmacy in 2020 and not only improved patient health outcomes. He's also been very pleased with the positive impact adherence packaging automation has had on his pharmacy’s financial health.
One thing that the COVID pandemic has shown is that pharmacies can thrive if they keep meeting customer needs. Parata's Mark Longley describes one way to do this, which is becoming a trend he's seeing across the pharmacy industry: Innovate with automation — especially in centralized services.
The collaborative partnership between PrescribeWellness and Kinney Drugs illustrates the importance and impact of telehealth and clinical contact services. When paired with local, frontline pharmacy providers, this comprehensive model for patient care can reach far and wide during the pandemic — and beyond.
Customer engagement can bring big benefits to your business — from increased brand awareness and trust, to improved customer retention and loyalty. Each customer...
As REMS (risk evaluation and mitigation strategy) programs grow to include more pharmaceutical product manufactures, wholesalers, and distributors, pharmacies face increased compliance challenges. Learn what to be aware of when ordering drugs in this category.
Adverse drug events (ADEs) have been the fourth leading cause of death over the past decade in the United States. A new study reveals the positive impact the MedWise Risk Score can have on predicting who is at risk.
Kraig McEwen, CEO of RedSail Technologies, LLC, spoke with ComputerTalk’s Maggie Lockwood about the company’s vision for the independent pharmacy market as its portfolio increases to include three major software players. With a long background in healthcare technology, McEwen sheds light on the importance of scale for independent pharmacy, as well as innovative technology platforms that respond to the healthcare trends toward value-based care.
A major contributor to the success of Memorial Hospital’s outpatient pharmacy expansion is also the smallest and simplest: a Kirby Lester KL1Plus verification-plus-counting device for prescription verification and counting.
Prescription costs are among the top issues in healthcare today. It is common for patients to ask about a discount plan. Will GoodRx and the proliferation of discount cards may finally be the disrupter to our complex, and often untransparent, pharmacy pricing system, not Amazon?
The lesson from COVID-19 testing is that pharmacy has an opportunity to tap into the yet largely unexplored opportunity of test/treat. The looming round of booster shots will underscore this need in community pharmacies.
Pharmaceutical manufacturers have announced that they will no longer provide 340B discounted product to contract pharmacies or will do so only if covered entities meet certain data submission requirements, setting off a chain of events that ultimately may force legislation that provides more definitive 340B guidelines.
The new federal health IT five-year strategic plan supports easier data sharing. It is an outcomes-driven plan designed to meet the needs of patients, caregivers, health providers, payers, researchers, developers, and innovators.
Pharmacists often think of the terms “brand” and “generic” as dichotomous and mutually exclusive, so it is not surprising that unbranded biologics, such as insulin and human growth hormone, seem to be causing confusion for pharmacies when it comes to product selection. We will address how unbranded biologics are being displayed in pharmacy management systems and what pharmacists need to do to make sure they are being reimbursed appropriately.